Sodium glycididazole clinical trials
How each study uses sodium glycididazole is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the sodium glycididazole studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Sodium Glycididazole
- 5
Studies by the year they started
5 studies that test it; most in 2016 (3)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2016 | 3 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 4
Shandong Cancer Hospital and Institute (3) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Shandong Luye Pharmaceutical Co., Ltd. (1)
Studies
Open first, then newest update. How each study uses sodium glycididazole is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Sodium Glycididazole Reduces the Adverse Reactions of Concurrent ChemoradiotherapyRecruitingPhase 2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT06667622Written as sodium glycididazoleHow we know
- A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCCCompletedPhase 4Shandong Cancer Hospital and InstituteNCT02721563Written as Sodium GlycididazoleHow we know
- A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCCTerminatedPhase 4Shandong Cancer Hospital and InstituteNCT02721576Written as Sodium GlycididazoleHow we know
- A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCCTerminatedPhase 4Shandong Cancer Hospital and InstituteNCT02721550Written as Sodium GlycididazoleHow we know
- A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous CarcinomaStatus unknownPhase 4Shandong Luye Pharmaceutical Co., Ltd.NCT00642239Written as Sodium GlycididazoleHow we know
Codes
What other systems call sodium glycididazole · ClinicalTrials.gg INT000359
- MeSH (NLM) C000603632sodium glycididazoleOne source NLM
- UNII (FDA) 5YV419FIJSSODIUM GLYCIDIDAZOLEConfirmed FDA, NLM, Wikidata
- Wikidata Q27263067sodium glycididazoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C77889Sodium GlycididazoleOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000603632 | sodium glycididazole | One source NLM |
| UNII (FDA) | 5YV419FIJS | SODIUM GLYCIDIDAZOLE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27263067 | sodium glycididazole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C77889 | Sodium Glycididazole | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.